The research, published in Science Translational Medicine, found that messenger RNA (mRNA) could be used to correct a rare liver genetic disease known as argininosuccinic aciduria in a mouse model of the disease.
Among the accomplishments of this year’s awardees are discoveries related to the role of altered pharmacokinetics in non-alcoholic fatty liver disease, the mechanisms of Parkinson’s disease neurodegeneration, the risk of COVID-19 to smokers and vapers, and the role of the microbiome in pregnancy and early developmental programming.
A new ACG Clinical Guideline on alcohol-associated liver disease (ALD) is featured in the January 2024 issue of The American Journal of Gastroenterology.
Hepatitis linked to alcohol, the most severe form of alcohol-associated liver disease, is increasingly prevalent, severe, and likely to involve emergency departments, according to a new analysis.
The gut microbiome, consisting of trillions of bacteria, viruses, and fungi, plays a crucial role in digestion, nutrient absorption, and the regulation of host metabolism and immunity.
Children’s Hospital Los Angeles has performed its 500th liver transplant—a milestone achievement that only a handful of pediatric centers in the country have reached.
With the rise in machine learning applications and artificial intelligence, it's no wonder that more and more scientists and researchers are turning to supercomputers. Supercomputers are commonly used for making predictions with advanced modeling and simulations. This can be applied to climate research, weather forecasting, genomic sequencing, space exploration, aviation engineering and more.
The December 2023 issue of ToxSci features a Contemporary Review exploring lipid mediator–driven inflammation following air pollution exposure, an In-Depth Review on the state of in vitro skin models, and ToxSpotlights on the effects of inhalation exposure to TCE and the dose-response assessment of non-mutagenic liver carcinogens.
Researchers at UChicago were able to predict postoperative infections in liver transplant patients by analyzing molecules in their poop — a key leap forward in exploring the connection between the gut microbiome and overall health.
SARS-CoV-2 persists in the respiratory tract, notably in patients with underlying co-morbidities including liver disease.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention.
Cedars-Sinai investigators have discovered how the liver defends itself against cancer. Their study, published in the peer-reviewed Journal of Hepatology, suggests targets for therapies to protect the liver both from cancers that originate there and cancers that spread to the liver from other parts of the body.
In the December issue of AJG: assisted reproductive technology among women with liver disease, strategies for incorporating sexual and gender minorities in GI research, anxiety/depression in GERD patients, and more.
This Thanksgiving marks a little more than 25 years since Christine Galan became the first person in the Western U.S. to have a combined organ transplant (heart and liver), and nearly five years since she returned to Cedars-Sinai for another organ transplant—this time, a kidney.
Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.
Researchers at the Research Institute of Molecular and Cellular Medicine of RUDN University have found that with significant damage to the liver, the spleen begins to actively help its neighbor in the abdominal cavity. It shares immune cells and triggers anti-inflammatory processes.
The former Metabolic and Fatty Liver Clinic at the University of Chicago Medicine is undergoing a name change, as part of a shift in language to drop stigmatizing words, precisely describe the condition and identify a subgroup of patients omitted under the former diagnostic criteria.
In a groundbreaking achievement for cancer treatment, research, and medical technology, the U.S. Food and Drug Administration (FDA) has granted approval for the HistoSonics’ Edison histotripsy device to treat liver tumors.
A study spearheaded by Oregon State University has shown why certain polyunsaturated fatty acids work to combat a dangerous liver condition, opening a new avenue of drug research for a disease that currently has no FDA-approved medications.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right